Biotech

All Articles

Arch closes $3B-plus fund to foster biopharma startups

.On the heels of a $3 billion fund coming from Bain Capital Life Sciences, Arc Project Allies is pro...

Orion to use Aitia's 'digital doubles' to locate brand-new cancer cells drugs

.Finnish biotech Orion has spied possible in Aitia's "digital identical twin" technician to develop ...

Windtree's shock med brings up high blood pressure in most up-to-date period 2 win

.While Windtree Therapeutics has actually struggled to develop the monetary origins required to surv...

2 cancer biotechs merge, making international impact

.OncoC4 is taking AcroImmune-- as well as its own in-house clinical production abilities-- under its...

Amgen files 1st stage 3 win for $400M chronic eczema drug

.Amgen has discussed (PDF) the 1st phase 3 data on its own $400 thousand eczema medication, connecti...

Biogen, UCB record phase 3 lupus gain after failing earlier test

.Biogen as well as UCB's depend developing into period 3 on the back of a broken study aims to have ...

Aptadir really hopes new RNA inhibitors may reverse complicated cancers cells

.Italian biotech Aptadir Therapeutics has actually introduced along with the pledge that its own pip...

Wave surfs DMD excellence to regulators' doors, sending stockpile

.Surge Lifestyle Sciences has met its own goal in a Duchenne muscular dystrophy (DMD) research, inst...

Sanofi plucks brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma layer, taking up the ...

Achilles drips cell therapy plan, supports for unemployments after overlooking 'industrial stability' goals

.Achilles Rehabs has torn up its own strategy. The British biotech is stopping work on its own clini...